Clinical Pharmacology Study to Evaluate the Total Systemic Exposure and Lung Bioavailability of CHF 5993 pMDI Combination in Healthy Volunteers

Conditions

• Asthma

Interventions

• DRUG: CHF 5993 HS 200/6/25 pMDI
• DRUG: CHF 5993 MS 100/6/25 pMDI
• DRUG: CHF 5993 HS 200/6/25 pMDI + Charcoal Block
• DRUG: CHF 5993 MS 100/6/25 pMDI + Charcoal Block
• DRUG: Placebo pMDI

Sponsor

Chiesi Farmaceutici S.p.A.